Emmis Acquisition (EMIS) vs SIGA Technologies (SIGA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Emmis Acquisition (EMIS) has outperformed SIGA Technologies (SIGA) over the past year, gaining 4.4% versus a loss of 58.9%. SIGA Technologies is the larger company by market cap ($172.5 million vs $163.4 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EMIS | SIGA |
|---|---|---|
| Share price | $10.36 | $2.40 |
| Market cap | $163.36M | $172.45M |
| 1-day change | +0.15% | -9.43% |
| YTD return | +4.07% | -60.72% |
| 1-year return | +4.39% | -58.90% |
| 5-year return | — | -71.90% |
| P/E ratio (TTM) | — | 240.00 |
| Forward P/E | — | 5.45 |
| EPS (TTM) | — | $0.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | — | $94.57M |
| Revenue growth (YoY) | — | -31.82% |
| Net income (latest FY) | — | $23.28M |
| Gross margin | — | 68.59% |
| Operating margin | — | 25.06% |
| Net margin | — | 24.61% |
| 52-week high | $10.38 | $7.11 |
| 52-week low | $9.92 | $2.30 |
| Distance from 52-week high | -0.24% | -66.24% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +35.42% |
| Average volume | 16.19K | 617.60K |
| Shares outstanding | 11.94M | 71.86M |
| Employees | — | 49 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EMIS has outperformed SIGA by 63.3 percentage points over the past year.
About Emmis Acquisition
EMIS stock →Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Health Care · Biotechnology: Pharmaceutical Preparations
About SIGA Technologies
SIGA stock →SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security market in the United States. The company's lead product is TPOXX, an antiviral drug for the treatment of human smallpox disease caused by variola virus.
Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees
EMIS vs SIGA FAQ
Which is bigger, Emmis Acquisition or SIGA Technologies?
SIGA Technologies (SIGA) is larger, with a market capitalization of $172.45M compared with $163.36M for Emmis Acquisition (EMIS).
Which stock has performed better over the past year, EMIS or SIGA?
EMIS returned +4.39% over the past 12 months, compared with -58.90% for SIGA (price return, excluding dividends). Past performance does not predict future results.
Are Emmis Acquisition and SIGA Technologies in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.